Journal article
Linezolid for children with tuberculous meningitis: More evidence required.
- Abstract:
- Tuberculous meningitis (TBM) is a devastating disease. With the currently available treatment regimens one in five children die and only a third of surviving children escape neurological sequelae.1 If there was any way of improving these outcomes significant mortality and morbidity would be averted. We were greatly interested, therefore, to read the study by Li et al regarding the use of linezolid in children with TBM in Beijing.
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 153.2KB, Terms of use)
-
- Publisher copy:
- 10.1097/INF.0000000000001464
Authors
+ Department for International Development
More from this funder
- Funding agency for:
- Basu Roy, R
- Grant:
- MR/K023446/1
+ Medical Research Council
More from this funder
- Funding agency for:
- Basu Roy, R
- Grant:
- MR/K023446/1
- Publisher:
- Lippincott, Williams & Wilkins
- Journal:
- Pediatric Infectious Diseases Journal More from this journal
- Volume:
- 36
- Issue:
- 4
- Pages:
- 439
- Publication date:
- 2017-04-01
- Acceptance date:
- 2016-10-14
- DOI:
- EISSN:
-
1532-0987
- ISSN:
-
0891-3668
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:685241
- UUID:
-
uuid:01845fae-b996-4242-83cc-f4d720b4c1fb
- Local pid:
-
pubs:685241
- Source identifiers:
-
685241
- Deposit date:
-
2017-05-24
- ARK identifier:
Terms of use
- Copyright holder:
- Wolters Kluwer Health, Inc
- Copyright date:
- 2017
- Notes:
- Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Lippincott, Williams & Wilkins at: http://dx.doi.org/10.1097/INF.0000000000001464
If you are the owner of this record, you can report an update to it here: Report update to this record